.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
. in washington before heading to baltimore for saturday's broadcast of
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
. and informal settlements. "this is far from the best start in life".
.
.